News

Find News

Filter articles

Showing 3231 to 3239 of 3239 results

US appeals court upholds AstraZeneca’s Seroquel XR patent

US19-02-2013Legal developments

The US Court of Appeals for the Federal Circuit has affirmed a 2012 ruling that AstraZeneca’s patent for antipsychotic drug Seroquel XR is valid and has been infringed by companies selling competing generics.

Teva faces $2 billion damages for selling generic Protonix

Israel18-02-2013

Israeli company Teva Pharmaceuticals could be forced to pay more than $2 billion in damages for selling a generic version of Nycomed and Pfizer’s heartburn reliever Protonix before the drug’s patent exclusivity expired in the US.

Australian court backs Myriad in human gene patent dispute

Australia18-02-2013

A judge at Australia’s Federal Court has upheld Myriad Genetics’ patent covering a human gene mutation linked to breast cancer, in the country’s first court ruling on whether isolated genes can be patented.

Bristol-Myers Squibb loses Baraclude patent fight with Teva

US14-02-2013

A US judge has declared pharmaceutical company Bristol-Myers Squibb’s patent covering its hepatitis B treatment Baraclude obvious and invalid.

India’s Patent Office revokes Sutent cancer drug patent

India14-02-2013Legal developments

India’s Patent Office has revoked pharmaceutical company Sugen and licensee Pfizer’s patent for the cancer drug Sutent, agreeing with Indian drugs maker Cipla that it lacks inventive step.

Mexican Senate proposes bill to reduce life term of medicine patents

Mexico01-02-2013Legal developments

The Mexican Senate has published a bill which, if adopted, will reduce the life term of medicine patents in Mexico by up to one year.

Nuvo Research and Apotex reach PENNSAID patent settlement

US31-01-2013Legal developments

Canadian pharmaceutical firms Nuvo Research and Apotex have agreed a patent settlement allowing Apotex to launch a generic version of Nuvo’s arthritis treatment PENNSAID in the US.

India publishes feedback on draft biotech guidelines

India31-01-2013Legal developments

India’s patent office has released comments submitted in response to draft examination guidelines for biotechnology patents published in December 2012.

University sues Virtus Pharmaceuticals for patent infringement

US17-12-2012

The University of Wisconsin’s alumni research foundation is suing Florida-based Virtus Pharmaceuticals for selling a calcium supplement it claims knowingly breaches one of its patents.

Showing 3231 to 3239 of 3239 results

LSIPR